文献速递产科

壳聚糖覆盖填塞物宫内填塞治疗产后出血

Uterine packing with chitosan-covered tamponade to treat postpartum hemorrhage.
PubMed 文献 · Am J Obstet Gynecol · 2023-08-23

产后出血是全球孕产妇死亡和疾病的重要原因,在资源有限国家发生率更高。常规宫缩剂和促凝血药物可能不足以控制危及生命的产后出血,严重时需输血、侵入性操作甚至子宫切除。壳聚糖覆盖填塞物宫内填塞是新兴止血工具,尤其适用于先进手术资源有限时,本文通过教学视频展示其逐步应用。

要点

  • 壳聚糖覆盖填塞物宫内填塞是治疗难治性产后出血的新兴手段。
  • 该方法最初源于军事医学中改良壳聚糖纱布的急性出血处理。
  • 2012年首次报道用于产科,显示可有效控制难治性产后出血。

核心结论

  • 壳聚糖覆盖填塞物宫内填塞是治疗难治性产后出血的新兴工具,尤其在先进手术资源有限时。

研究设计与样本

  • 本文为教学视频,展示壳聚糖覆盖填塞物宫内填塞治疗难治性产后出血的逐步应用。

主要发现

  • 2012年首次描述产科使用,显示壳聚糖覆盖填塞物是控制持续难治性产后出血的有效干预。
  • 进一步研究显示子宫切除和输血减少。
  • 该方法报告不足,尚未成为全球确立的方法。

临床怎么用

  • 常规使用缩宫素、前列腺素及纤维蛋白原和氨甲环酸等支持凝血药物可能不足以控制危及生命的产后出血。
  • 严重产后出血需增加输血和侵入性技术,如宫内球囊填塞、压迫缝合和动脉结扎,极端情况需子宫切除。
  • 壳聚糖覆盖填塞物宫内填塞是产科团队的新兴工具,尤其当先进手术和其他侵入性选项资源有限时。

局限性

  • 该方法报告不足,尚未成为全球确立的方法。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Postpartum hemorrhage remains a major cause of maternal mortality and morbidity worldwide with higher rates found in resource-challenged countries. Conventional use of uterotonics such as oxytocin, prostaglandins, and medications to support coagulation, such as fibrinogen and tranexamic acid, are helpful but may not be sufficient to arrest life-threatening postpartum hemorrhage. Severe postpartum hemorrhage leads to an increased need for blood transfusions and the use of invasive techniques, such as intrauterine balloon tamponade, compression sutures, and arterial ligation, as advanced steps in the management cascade. In extreme cases where hemorrhage is resistant to these therapies, a hysterectomy may be necessary to avoid possible maternal death. Uterine packing with a chitosan-covered tamponade is an emerging tool in the armamentarium of the obstetrical team, especially when resources for advance surgical and other invasive options may be limited. Modified chitosan-impregnated gauze was originally described in the management of acute hemorrhage in the field of military medicine, combining the physiological antihemorrhaging effect of modified chitosan with a compression tamponade for the acute treatment of wound bleeding. The first described use in obstetrics was in 2012, showing that the chitosan-covered tamponade is an effective intervention to arrest ongoing therapy-resistant postpartum hemorrhage. Further studies showed a reduction in hysterectomies and blood transfusions. The method is, however, underreported and is not yet an established method used worldwide. To demonstrate the step-by-step application of the intrauterine chitosan-covered tamponade in the management of therapy-resistant postpartum hemorrhage, we have produced a teaching video to illustrate the important steps and techniques to optimize the effectiveness and safety of this novel intervention.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Henrich W, Dückelmann A, Braun T, et al. Uterine packing with chitosan-covered tamponade to treat postpartum hemorrhage. Am J Obstet Gynecol. 2023. PMID: 38462249. doi:10.1016/j.ajog.2022.11.1297

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。